Adrija Exim Private Limited
About Adrija Exim Private Limited
Data last updated:
Adrija Exim Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 27 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2012PTC184125. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Kuntal Paul and Shalini Bose.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹45,113, a growth of 47% compared to the previous year. For the same year it recorded a net loss of ₹1,675 (net margin -3.7%) and EBITDA of -₹1,675 (EBITDA margin -3.7%). Revenue has grown at a compounded annual rate (CAGR) of 133% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Adrija Exim Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMaa Laxmi Apartment – II Ground Floor Flat No. – D De – 105/1 Narayantala(East) Aswinigar, Baguiati, Kolkata, West Bengal, India – 700159
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Adrija Exim Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Adrija Exim Private Limited
FY 2025 filings availableAdrija Exim Private Limited reported revenue of ₹45,113 (up 47% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 133% over five years, including 47% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1,675 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,675 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.7% | ||||
| Net Profit Margin | -3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adrija Exim Private Limited, buy the company report.
Board of directors of Adrija Exim Private Limited
Adrija Exim has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kuntal Paul | Director | 10 Mar 2022 | 4 Years 7 Months | Current |
| Shalini Bose | Director | 10 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
Adrija Exim Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxlife Drugs Private Limited. | ₹47,820 (FY 2025) | New Delhi, Delhi, India | ||||
| Darshan Pharmacuticals Private Limited | ₹46,760 (FY 2024) | -93.0% | Mumbai, Maharashtra, India | |||
| Adrija Exim Private Limitedthis company | ₹45,113 (FY 2025) | -₹1,675 | -3.7% | 47.0% | Kolkata, West Bengal, India | |
| VSN Pharmaceuticals Private Limited | ₹45,110 (FY 2025) | 0.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Adrija Exim Private Limited, buy the company report.
Auditor
Adrija Exim Private Limited is audited by CHAYAN GUPTA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHAYAN GUPTA & ASSOCIATES | FY 2017 | 324471E |
Shareholding
The shareholding of Adrija Exim Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Adrija Exim Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adrija Exim Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adrija Exim Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Adrija Exim has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Adrija Exim Private Limited, buy the company report.
Recent activity
Adrija Exim Private Limited has 10 board changes on record since 2012: 6 appointments and 4 cessations. The latest: Debasis Bose ceased to be Additional Director on 10 Oct 2022.
1 earlier event is in the company report.
Frequently asked questions
Adrija Exim is an active private limited company based in Kolkata, West Bengal, India. The company works in retail trading, within the trading industry. It was incorporated on 27 July 2012 (14+ years old) and is registered under CIN U51909WB2012PTC184125.
Adrija Exim has 2 current directors:
- Kuntal Paul - Director
- Shalini Bose - Director
The latest financial statements of Adrija Exim on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Adrija Exim has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Adrija Exim is U51909WB2012PTC184125. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adrija Exim was incorporated on 27 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Adrija Exim by revenue are Maxlife Drugs Private Limited, Darshan Pharmacuticals Private Limited, VSN Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (retail trading).
Debasis Bose ceased to be Additional Director on 10 Oct 2022. Ashok Sengupta ceased to be Director on 11 Mar 2022. Nandita Saha ceased to be Director on 11 Mar 2022. Adrija Exim has 10 board changes on record in total.
The registered office of Adrija Exim is at Maa Laxmi Apartment – II Ground Floor Flat No. – D De – 1051 NarayantalaEast Aswinigar, Baguiati, Kolkata, West Bengal, India – 700159.
Adrija Exim operates in the trading industry, in the retail trading segment.
The compliance status of Adrija Exim is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.